Do analysts rate NGVT or IOSP?

Ingevity currently has a consensus price target of $80.00, indicating a potential upside of 14.87%. Given Ingevity's stronger consensus rating and higher probable upside, equities analysts plainly believe Ingevity is more favorable than Innospec. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ingevity 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40 Innospec 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation & earnings, NGVT or IOSP?

Innospec has higher revenue and earnings than Ingevity. Innospec is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ingevity $1.17B 2.05 -$167.10M $1.47 47.38 Innospec $1.78B 1.29 $116.60M $4.90 19.03

Is NGVT or IOSP more profitable?

Innospec has a net margin of 6.60% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Innospec's return on equity. Company Net Margins Return on Equity Return on Assets Ingevity 4.65% 284.70% 10.82% Innospec 6.60% 9.22% 6.74%

Which has preferable earnings & valuation, AVNT or NGVT?

Avient has higher revenue and earnings than Ingevity. Avient is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avient $3.33B 1.14 $81.90M $1.85 22.41 Ingevity $1.17B 2.05 -$167.10M $1.47 47.38

Is AVNT or NGVT more profitable?

Avient has a net margin of 5.10% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Avient's return on equity. Company Net Margins Return on Equity Return on Assets Avient 5.10% 11.64% 4.67% Ingevity 4.65% 284.70% 10.82%

Which has better earnings & valuation, TKR or NGVT?

Timken has higher revenue and earnings than Ingevity. Timken is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Timken $4.76B 1.74 $288.40M $3.69 32.32 Ingevity $1.17B 2.05 -$167.10M $1.47 47.38

Is TKR or NGVT more profitable?

Timken has a net margin of 5.43% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Timken's return on equity. Company Net Margins Return on Equity Return on Assets Timken 5.43% 12.63% 6.21% Ingevity 4.65% 284.70% 10.82%

Which has stronger earnings and valuation, NGVT or ESI?

Element Solutions has higher revenue and earnings than Ingevity. Element Solutions is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ingevity $1.17B 2.05 -$167.10M $1.47 47.38 Element Solutions $3.15B 2.65 $190.80M $0.74 46.35

Which has preferable earnings and valuation, EMN or NGVT?

Eastman Chemical has higher revenue and earnings than Ingevity. Eastman Chemical is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Eastman Chemical $8.75B 0.89 $474M $3.84 17.72 Ingevity $1.17B 2.05 -$167.10M $1.47 47.38

Ingevity (NGVT) Competitors

$69.64 +2.51 (+3.74%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$69.44 -0.20 (-0.29%)

As of 09/11/2026 07:30 PM Eastern

Compare

NGVT vs. IOSP, AVNT, TKR, ESI, and EMN

Should you buy Ingevity stock or one of its competitors? Ingevity's main competitors and comparable companies include Innospec (IOSP), Avient (AVNT), Timken (TKR), Element Solutions (ESI), and Eastman Chemical (EMN). Companies are selected based on similarities in market, industry, and size.

How does Ingevity compare to Innospec?

Ingevity (NYSE:NGVT) and Innospec (NASDAQ:IOSP) are both mid-cap materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

In the previous week, Innospec had 2 more articles in the media than Ingevity. MarketBeat recorded 2 mentions for Innospec and 0 mentions for Ingevity. Innospec's average media sentiment score of 1.70 beat Ingevity's score of 1.48 indicating that Innospec is being referred to more favorably in the news media.

Company	Overall Sentiment
Ingevity	Positive
Innospec	Very Positive

Innospec has a net margin of 6.60% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ingevity	4.65%	284.70%	10.82%
Innospec	6.60%	9.22%	6.74%

Innospec has higher revenue and earnings than Ingevity. Innospec is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ingevity	$1.17B	2.05	-$167.10M	$1.47	47.38
Innospec	$1.78B	1.29	$116.60M	$4.90	19.03

91.6% of Ingevity shares are held by institutional investors. Comparatively, 96.6% of Innospec shares are held by institutional investors. 0.9% of Ingevity shares are held by insiders. Comparatively, 1.5% of Innospec shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Ingevity currently has a consensus price target of $80.00, indicating a potential upside of 14.87%. Given Ingevity's stronger consensus rating and higher probable upside, equities analysts plainly believe Ingevity is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ingevity	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Ingevity has a beta of 1.17, indicating that its share price is 17% more volatile than the broader market. Comparatively, Innospec has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

Summary

Ingevity and Innospec tied by winning 8 of the 16 factors compared between the two stocks.

How does Ingevity compare to Avient?

Avient (NYSE:AVNT) and Ingevity (NYSE:NGVT) are both mid-cap materials companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

Avient has a beta of 1.29, indicating that its stock price is 29% more volatile than the broader market. Comparatively, Ingevity has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market.

95.5% of Avient shares are held by institutional investors. Comparatively, 91.6% of Ingevity shares are held by institutional investors. 0.9% of Avient shares are held by insiders. Comparatively, 0.9% of Ingevity shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Avient has higher revenue and earnings than Ingevity. Avient is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avient	$3.33B	1.14	$81.90M	$1.85	22.41
Ingevity	$1.17B	2.05	-$167.10M	$1.47	47.38

Avient has a net margin of 5.10% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Avient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avient	5.10%	11.64%	4.67%
Ingevity	4.65%	284.70%	10.82%

Avient currently has a consensus price target of $46.71, suggesting a potential upside of 12.67%. Ingevity has a consensus price target of $80.00, suggesting a potential upside of 14.87%. Given Ingevity's higher possible upside, analysts plainly believe Ingevity is more favorable than Avient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avient	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Ingevity	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Ingevity's average media sentiment score of 1.48 beat Avient's score of 0.82 indicating that Ingevity is being referred to more favorably in the news media.

Company	Overall Sentiment
Avient	Positive
Ingevity	Positive

Summary

Avient beats Ingevity on 8 of the 15 factors compared between the two stocks.

How does Ingevity compare to Timken?

Timken (NYSE:TKR) and Ingevity (NYSE:NGVT) are related mid-cap companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

89.1% of Timken shares are held by institutional investors. Comparatively, 91.6% of Ingevity shares are held by institutional investors. 8.1% of Timken shares are held by company insiders. Comparatively, 0.9% of Ingevity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Timken has higher revenue and earnings than Ingevity. Timken is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Timken	$4.76B	1.74	$288.40M	$3.69	32.32
Ingevity	$1.17B	2.05	-$167.10M	$1.47	47.38

In the previous week, Timken had 21 more articles in the media than Ingevity. MarketBeat recorded 21 mentions for Timken and 0 mentions for Ingevity. Ingevity's average media sentiment score of 1.48 beat Timken's score of 1.19 indicating that Ingevity is being referred to more favorably in the news media.

Company	Overall Sentiment
Timken	Positive
Ingevity	Positive

Timken has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market. Comparatively, Ingevity has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market.

Timken presently has a consensus price target of $145.50, indicating a potential upside of 22.02%. Ingevity has a consensus price target of $80.00, indicating a potential upside of 14.87%. Given Timken's stronger consensus rating and higher possible upside, equities analysts plainly believe Timken is more favorable than Ingevity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Timken	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70
Ingevity	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Timken has a net margin of 5.43% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Timken's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Timken	5.43%	12.63%	6.21%
Ingevity	4.65%	284.70%	10.82%

Summary

Timken beats Ingevity on 10 of the 16 factors compared between the two stocks.

How does Ingevity compare to Element Solutions?

Ingevity (NYSE:NGVT) and Element Solutions (NYSE:ESI) are both mid-cap materials companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends.

In the previous week, Element Solutions had 3 more articles in the media than Ingevity. MarketBeat recorded 3 mentions for Element Solutions and 0 mentions for Ingevity. Ingevity's average media sentiment score of 1.48 beat Element Solutions' score of 0.75 indicating that Ingevity is being referred to more favorably in the media.

Company	Overall Sentiment
Ingevity	Positive
Element Solutions	Positive

Ingevity has a beta of 1.17, indicating that its share price is 17% more volatile than the broader market. Comparatively, Element Solutions has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

91.6% of Ingevity shares are owned by institutional investors. Comparatively, 92.3% of Element Solutions shares are owned by institutional investors. 0.9% of Ingevity shares are owned by insiders. Comparatively, 6.2% of Element Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Ingevity currently has a consensus price target of $80.00, suggesting a potential upside of 14.87%. Element Solutions has a consensus price target of $46.70, suggesting a potential upside of 36.17%. Given Element Solutions' stronger consensus rating and higher possible upside, analysts clearly believe Element Solutions is more favorable than Ingevity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ingevity	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Element Solutions	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	4 Strong Buy rating(s)	3.15

Element Solutions has a net margin of 5.67% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Element Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ingevity	4.65%	284.70%	10.82%
Element Solutions	5.67%	14.88%	7.51%

Element Solutions has higher revenue and earnings than Ingevity. Element Solutions is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ingevity	$1.17B	2.05	-$167.10M	$1.47	47.38
Element Solutions	$3.15B	2.65	$190.80M	$0.74	46.35

Summary

Element Solutions beats Ingevity on 12 of the 17 factors compared between the two stocks.

How does Ingevity compare to Eastman Chemical?

Eastman Chemical (NYSE:EMN) and Ingevity (NYSE:NGVT) are both mid-cap materials companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability.

Eastman Chemical has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market. Comparatively, Ingevity has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market.

Eastman Chemical has higher revenue and earnings than Ingevity. Eastman Chemical is trading at a lower price-to-earnings ratio than Ingevity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eastman Chemical	$8.75B	0.89	$474M	$3.84	17.72
Ingevity	$1.17B	2.05	-$167.10M	$1.47	47.38

In the previous week, Eastman Chemical had 16 more articles in the media than Ingevity. MarketBeat recorded 16 mentions for Eastman Chemical and 0 mentions for Ingevity. Ingevity's average media sentiment score of 1.48 beat Eastman Chemical's score of 1.47 indicating that Ingevity is being referred to more favorably in the news media.

Company	Overall Sentiment
Eastman Chemical	Positive
Ingevity	Positive

Eastman Chemical currently has a consensus target price of $79.17, suggesting a potential upside of 16.33%. Ingevity has a consensus target price of $80.00, suggesting a potential upside of 14.87%. Given Eastman Chemical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Eastman Chemical is more favorable than Ingevity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eastman Chemical	0 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.43
Ingevity	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

83.7% of Eastman Chemical shares are held by institutional investors. Comparatively, 91.6% of Ingevity shares are held by institutional investors. 2.6% of Eastman Chemical shares are held by insiders. Comparatively, 0.9% of Ingevity shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Eastman Chemical has a net margin of 4.99% compared to Ingevity's net margin of 4.65%. Ingevity's return on equity of 284.70% beat Eastman Chemical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eastman Chemical	4.99%	9.46%	3.78%
Ingevity	4.65%	284.70%	10.82%

Summary

Eastman Chemical beats Ingevity on 9 of the 16 factors compared between the two stocks.

Get Ingevity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NGVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NGVT vs. The Competition

Export

Metric	Ingevity	Chemicals Industry	Materials Sector	NYSE Exchange
Market Cap	$2.31B	$11.30B	$4.92B	$23.17B
Dividend Yield	N/A	2.83%	4.68%	3.56%
P/E Ratio	47.38	37.71	26.19	28.71
Price / Sales	2.05	55.21	4,792.64	94.44
Price / Cash	5.47	15.04	26.92	33.82
Price / Book	83.91	3.24	10.24	4.74
Net Income	-$167.10M	$222.40M	$158.16M	$1.07B
7 Day Performance	-1.30%	-1.50%	-1.45%	-2.00%
1 Month Performance	-8.90%	-0.60%	7.08%	-2.69%
1 Year Performance	19.89%	16.05%	37.22%	10.45%

Ingevity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NGVT Ingevity	2.0992 of 5 stars	$69.64 +3.7%	$80.00 +14.9%	+18.4%	$2.31B	$1.17B	47.38	1,500	Positive News
IOSP Innospec	3.3344 of 5 stars	$93.37 -0.6%	N/A	+11.5%	$2.30B	$1.78B	19.06	2,450	Positive News
AVNT Avient	3.7673 of 5 stars	$42.60 -1.9%	$46.71 +9.7%	+10.2%	$3.91B	$3.26B	23.02	9,000
TKR Timken	4.8712 of 5 stars	$124.03 +0.7%	$145.50 +17.3%	+50.6%	$8.60B	$4.58B	33.61	19,000	Trending News Analyst Revision
ESI Element Solutions	4.6785 of 5 stars	$36.20 +0.5%	$46.00 +27.1%	+30.0%	$8.82B	$2.55B	48.91	5,200	Analyst Downgrade Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NGVT) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ingevity (NGVT) Competitors